We are building a strong, well-run business, structured to deliver sustainable results over the long term.
Along with biotechnology leadership, the ARIAD team is focused on its commitment
to deliver long-term value to investors through solid business execution. That means
maintaining disciplined cost control, thoughtful capital deployment and the highest
standards of corporate governance.
Webcast - Replay ARIAD Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference 05/14/13 at 10:00 a.m. PT
ARIAD Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference Tuesday, May 14, 2013 10:00 a.m. PT